Sanofi and Hisamitsu Pharmaceuticals Create Merger for OTC Products
This article was originally published in PharmAsia News
Executive Summary
Sanofi and Hisamitsu Pharmaceuticals announced a mutual agreement to establish a joint venture for marketing allergy-related over-the-counter projects on June 12.